A rapid and sensitive assay for the quantitation of carboxypeptidase N, an important regulator of inflammation.

[1]  J. Willemse,et al.  LETTERS TO THE EDITOR: Fast kinetic assay for the determination of procarboxypeptidase U (TAFI) in human plasma , 2005, Journal of thrombosis and haemostasis : JTH.

[2]  M. Nesheim,et al.  HISTORICAL SKETCH: The discovery of TAFI , 2005, Journal of thrombosis and haemostasis : JTH.

[3]  Fuquan Yang,et al.  Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1alpha in the circulation. , 2005, Blood.

[4]  R. Verkerk,et al.  Development of a fast kinetic method for the determination of carboxypeptidase U (TAFIa) using C-terminal arginine containing peptides as substrate. , 2005, Analytical biochemistry.

[5]  M. Boffa,et al.  Two Naturally Occurring Variants of TAFI (Thr-325 and Ile-325) Differ Substantially with Respect to Thermal Stability and Antifibrinolytic Activity of the Enzyme* , 2002, The Journal of Biological Chemistry.

[6]  M. Boffa,et al.  Plasma and Recombinant Thrombin-activable Fibrinolysis Inhibitor (TAFI) and Activated TAFI Compared with Respect to Glycosylation, Thrombin/Thrombomodulin-dependent Activation, Thermal Stability, and Enzymatic Properties* , 1998, The Journal of Biological Chemistry.

[7]  D. Hendriks,et al.  Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen. , 1994, The Journal of biological chemistry.

[8]  S. Scharpe,et al.  Colorimetric assay for carboxypeptidase N in serum. , 1986, Clinica chimica acta; international journal of clinical chemistry.

[9]  S. Scharpe,et al.  Assay of carboxypeptidase N activity in serum by liquid-chromatographic determination of hippuric acid. , 1985, Clinical chemistry.

[10]  T. Hugli,et al.  Familial carboxypeptidase N deficiency. , 1980, Annals of internal medicine.

[11]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[12]  H. Müller-Eberhard,et al.  Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. , 1970, The Journal of clinical investigation.

[13]  E. Erdos,et al.  An enzyme in human blood plasma that inactivates bradykinin and kallidins. , 1962, Biochemical pharmacology.

[14]  J. Willemse,et al.  Measurement of procarboxypeptidase U (TAFI) in human plasma: a laboratory challenge. , 2006, Clinical chemistry.

[15]  J. Curd,et al.  Decreased synthesis of serum carboxypeptidase N (SCPN) in familial SCPN deficiency , 2004, Journal of Clinical Immunology.

[16]  R. Wetsel,et al.  Carboxypeptidase N: a pleiotropic regulator of inflammation. , 2004, Molecular immunology.

[17]  R. Hegele,et al.  DNA polymorphism and mutations in CPN1, including the genomic basis of carboxypeptidase N deficiency , 2003, Journal of Human Genetics.

[18]  S. Scharpe,et al.  A labile enzyme in fresh human serum interferes with the assay of carboxypeptidase N. , 1989, Clinical chemistry.